The end of social confinement and COVID-19 re-emergence risk

被引:0
|
作者
Leonardo López
Xavier Rodó
机构
[1] Barcelona Institute for Global Health,Climate and Health Program
[2] ICREA,undefined
来源
Nature Human Behaviour | 2020年 / 4卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The lack of effective pharmaceutical interventions for SARS-CoV-2 raises the possibility of COVID-19 recurrence. We explore different post-confinement scenarios by using a stochastic modified SEIR (susceptible–exposed–infectious–recovered) model that accounts for the spread of infection during the latent period and also incorporates time-decaying effects due to potential loss of acquired immunity, people’s increasing awareness of social distancing and the use of non-pharmaceutical interventions. Our results suggest that lockdowns should remain in place for at least 60 days to prevent epidemic growth, as well as a potentially larger second wave of SARS-CoV-2 cases occurring within months. The best-case scenario should also gradually incorporate workers in a daily proportion at most 50% higher than during the confinement period. We show that decaying immunity and particularly awareness and behaviour have 99% significant effects on both the current wave of infection and on preventing COVID-19 re-emergence. Social distancing and individual non-pharmaceutical interventions could potentially remove the need for lockdowns.
引用
收藏
页码:746 / 755
页数:9
相关论文
共 50 条
  • [1] The end of social confinement and COVID-19 re-emergence risk
    Lopez, Leonardo
    Rodo, Xavier
    [J]. NATURE HUMAN BEHAVIOUR, 2020, 4 (07) : 746 - +
  • [2] Necessary problems in re-emergence of COVID-19
    Chen, Si
    Ren, Lin-Zhu
    Ouyang, Hong-Sheng
    Liu, Shen
    Zhang, Li-Ying
    [J]. WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (01) : 1 - 7
  • [3] Necessary problems in re-emergence of COVID-19
    Si Chen
    Lin-Zhu Ren
    Hong-Sheng Ouyang
    Shen Liu
    Li-Ying Zhang
    [J]. World Journal of Clinical Cases, 2021, 9 (01) : 1 - 7
  • [4] Re-emergence of the Ebola virus in a context of Covid-19
    Oger, Adalie
    [J]. ACTUALITES PHARMACEUTIQUES, 2021, 60 (608): : 36 - 39
  • [5] Worried well and Covid-19: Re-emergence of an old quandary
    Chatterjee, Seshadri Sekhar
    Vora, Mansi
    Malathesh, Barikar C.
    Bhattacharyya, Ranjan
    [J]. ASIAN JOURNAL OF PSYCHIATRY, 2020, 54
  • [6] The re-emergence from the COVID-19 epidemic of Beijing Xinfadi Market
    Chen, Haiqian
    Shi, Leiyu
    Zhang, Yuyao
    Wang, Xiaohan
    Sun, Gang
    [J]. MEDICINE, 2021, 100 (31) : E26718
  • [7] COVAN is the new HIVAN: the re-emergence of collapsing glomerulopathy with COVID-19
    Juan Carlos Q. Velez
    Tiffany Caza
    Christopher P. Larsen
    [J]. Nature Reviews Nephrology, 2020, 16 : 565 - 567
  • [8] The re-emergence of COVID-19 in China is a big threat for the world: Associated risk factors and preventive measures
    Barai, Sampa
    Kadir, Mohammad Fahim
    Shahriar, Mohammad
    Islam, Md. Rabiul
    [J]. ANNALS OF MEDICINE AND SURGERY, 2023, 85 (02): : 348 - 350
  • [9] Re-Emergence of HMPV in Gwangju, South Korea, after the COVID-19 Pandemic
    Cho, Sun-Ju
    Kim, Sun-Hee
    Lee, Hongsu
    Lee, Yeong-Un
    Mun, Jeongeun
    Park, Sujung
    Park, Jungwook
    Park, Ji-Su
    Lee, Kwangho
    Lee, Cheong-mi
    Seo, Jinjong
    Kim, Yonghwan
    Chung, Yoon-Seok
    [J]. PATHOGENS, 2023, 12 (10):
  • [10] Re-emergence of SARS-CoV2 in a discharged COVID-19 case
    Zhou, Mi
    Li, Qingfeng
    Cao, Lin
    Liu, Yingfen
    Zha, Yi
    Xie, He
    Zeng, Mingquan
    Shi, Xuemei
    Gao, Yueqing
    Xie, Liqiu
    Luo, Mei
    Zeng, Yilan
    [J]. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2020, 53 (03) : 501 - 502